Published in Br J Cancer on May 21, 2013
Drug repurposing in oncology-patient and health systems opportunities. Nat Rev Clin Oncol (2015) 1.25
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. EBioMedicine (2016) 1.16
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma. Ecancermedicalscience (2015) 0.96
Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer (2015) 0.96
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation. Nat Commun (2015) 0.95
Metronomics as maintenance treatment in oncology: time for chemo-switch. Front Oncol (2014) 0.94
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan. Ecancermedicalscience (2014) 0.94
Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget (2014) 0.89
Signaling pathways in the development of infantile hemangioma. J Hematol Oncol (2014) 0.89
Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients. Onco Targets Ther (2015) 0.83
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma. Br J Clin Pharmacol (2015) 0.82
Formalizing an integrative, multidisciplinary cancer therapy discovery workflow. Cancer Res (2013) 0.81
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. Sci Rep (2016) 0.80
Pathological hypertrophy reverses β2-adrenergic receptor-induced angiogenesis in mouse heart. Physiol Rep (2015) 0.80
Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'. Br J Cancer (2013) 0.79
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway. Oncotarget (2016) 0.78
Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World J Gastroenterol (2015) 0.78
Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth. Oncotarget (2016) 0.77
Prevention of skin carcinogenesis by the β-blocker carvedilol. Cancer Prev Res (Phila) (2014) 0.77
NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil. Oncotarget (2016) 0.77
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience (2016) 0.76
Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression. J Virol (2015) 0.76
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation. Am J Hematol (2016) 0.75
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina. Ecancermedicalscience (2016) 0.75
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai. Ecancermedicalscience (2016) 0.75
Drug repositioning in sarcomas and other rare tumors. EBioMedicine (2016) 0.75
The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review. Geburtshilfe Frauenheilkd (2016) 0.75
Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models. Oncotarget (2016) 0.75
Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation. Oncotarget (2016) 0.75
Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression. Sci Rep (2017) 0.75
Renal Drug Transporters and Drug Interactions. Clin Pharmacokinet (2017) 0.75
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul (1984) 35.22
Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res (2010) 12.96
Propranolol for severe hemangiomas of infancy. N Engl J Med (2008) 11.32
Guidelines for the welfare and use of animals in cancer research. Br J Cancer (2010) 6.97
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol (2008) 6.66
Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem (1999) 6.54
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med (2010) 6.34
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol (2009) 5.12
Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J (1997) 4.99
The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res (2010) 3.36
Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol (2011) 2.99
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol (2011) 2.90
Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget (2010) 2.64
Treatment with β-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med (2011) 2.53
Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. Ann Surg (2012) 2.35
Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res (2011) 1.84
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol (2010) 1.57
β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev (2011) 1.55
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget (2011) 1.54
Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol (2012) 1.42
Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. J Pediatr Hematol Oncol (2011) 1.33
Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. Mol Cancer Ther (2004) 1.24
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol (2013) 1.20
Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene (2002) 1.12
Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med Pediatr Oncol (2000) 1.10
Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. Brain Behav Immun (2012) 1.08
Neuroblastoma. Surg Oncol (2007) 1.05
Microtubule-targeted agents: when mitochondria become essential to chemotherapy. Biochim Biophys Acta (2011) 1.02
Histological profile of tumours from MYCN transgenic mice. J Clin Pathol (2008) 1.01
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma. Eur J Cancer (2007) 1.00
Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res (1989) 0.98
ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties. Mol Cancer Ther (2010) 0.98
Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein. Fundam Clin Pharmacol (2006) 0.96
Multi-parametric analysis and modeling of relationships between mitochondrial morphology and apoptosis. PLoS One (2012) 0.95
Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. Int J Pharm (2001) 0.93
Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells. Angiogenesis (2012) 0.91
β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. Eur J Pharmacol (2011) 0.90
Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts. Biochim Biophys Acta (1994) 0.88
Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment. Neoplasia (2013) 0.88
Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Biochem Pharmacol (1999) 0.87
Untangling the web: mitochondrial fission and apoptosis. Dev Cell (2004) 0.85
Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro. Radiat Oncol (2010) 0.85
Carvedilol in glioma treatment alone and with imatinib in vitro. Int J Oncol (2010) 0.85
Giant, dopamine secreting thoracoabdominal neuroblastoma in a 2-year-old: rapid preoperative blockade with labetalol. J Pediatr Hematol Oncol (2010) 0.83
Catecholamine-secreting neuroblastoma in a 4-month-old infant: perioperative management. J Clin Anesth (2009) 0.83
Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Cancer Sci (2003) 0.80
Inhibitors of P-glycoprotein-mediated daunomycin transport in rat liver canalicular membrane vesicles. J Pharm Sci (1996) 0.78
A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. N Engl J Med (1998) 7.20
Genetic engineering of Schizosaccharomyces pombe: a system for gene disruption and replacement using the ura4 gene as a selectable marker. Mol Gen Genet (1988) 6.35
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet (2001) 4.33
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (1984) 4.27
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet (1999) 3.61
The superficial femoral vein. A potentially lethal misnomer. JAMA (1995) 3.40
Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity (1997) 3.33
Health care crisis from a trauma center perspective: The LA story. JAMA (1996) 3.24
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest (1997) 2.96
Randomized trial comparing traditional Chinese medical acupuncture, therapeutic massage, and self-care education for chronic low back pain. Arch Intern Med (2001) 2.67
High-resolution mapping of crossovers in human sperm defines a minisatellite-associated recombination hotspot. Mol Cell (1998) 2.41
EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I--Factors associated with carer burden. Int J Geriatr Psychiatry (1999) 2.36
Minor psychiatric morbidity and the threat of redundancy in a professional group. Psychol Med (1982) 2.36
Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet (2000) 2.26
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Alternative or additional medicine? A new dilemma for the doctor. J R Coll Gen Pract (1988) 2.16
Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia (2005) 2.08
Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics (1992) 2.04
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN. J Clin Oncol (2000) 2.02
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.02
Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med (1998) 1.87
Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol (1991) 1.86
One hundred five penetrating cardiac injuries: a 2-year prospective evaluation. J Trauma (1998) 1.84
Occupational respiratory disease in mining. Occup Med (Lond) (2004) 1.84
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol (2001) 1.82
Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis (2007) 1.78
Penetrating injuries to the subclavian and axillary vessels. J Am Coll Surg (1999) 1.75
Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharmacol (2014) 1.74
Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV. Immunol Rev (1991) 1.72
Neuropsychological dysfunction following repeat concussions in jockeys. J Neurol Neurosurg Psychiatry (2006) 1.71
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation (1995) 1.70
Analysis of colorectal cancer stage among HMO members targeted for screening. Arch Intern Med (1997) 1.69
Cloning and characterization of the rad4 gene of Schizosaccharomyces pombe; a gene showing short regions of sequence similarity to the human XRCC1 gene. Nucleic Acids Res (1991) 1.66
Self-reported illness and general practice consultations in Asian-born and British-born residents of West London. Soc Psychiatry (1986) 1.66
Differential distribution of subsets of myofibrillar proteins in cardiac nonstriated and striated myofibrils. J Cell Biol (1990) 1.65
Gunshot injuries to the liver: the role of selective nonoperative management. J Am Coll Surg (1999) 1.62
A longitudinal study of psychotropic drug prescription. Psychol Med (1982) 1.61
Penetrating cardiac injuries: a prospective study of variables predicting outcomes. J Am Coll Surg (1998) 1.60
Suppression of infection by famine and its activation by refeeding--a paradox? Perspect Biol Med (1977) 1.60
Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest (1992) 1.59
Acute respiratory infections in children. A global public-health problem. N Engl J Med (1984) 1.57
An evaluation of practice nurses working with general practitioners to treat people with depression. Br J Gen Pract (1998) 1.55
The role of beta-tubulin isotypes in resistance to antimitotic drugs. Biochim Biophys Acta (2001) 1.54
Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness? Clin Infect Dis (1998) 1.52
Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol (1999) 1.51
Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med (2006) 1.50
Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ (2000) 1.48
Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group. Heart (2000) 1.48
A randomised study of "wet wraps" versus conventional treatment for atopic eczema. Arch Dis Child (2005) 1.44
Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet (1992) 1.44
In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother (2000) 1.43
What proportion of basic surgical trainees continue in a surgical career? A survey of the factors which are important in influencing career decisions. Surgeon (2009) 1.43
Myosin IB null mutants of Dictyostelium exhibit abnormalities in motility. Cell Motil Cytoskeleton (1991) 1.42
F-actin sequesters elongation factor 1alpha from interaction with aminoacyl-tRNA in a pH-dependent reaction. J Cell Biol (1996) 1.40
Histopathology of gastric dysplasias: correlations with gastric juice chemistry. Am J Surg Pathol (1979) 1.40
The linear relationship between changes in childhood growth velocity and topical glucocorticoid dose. Allergy Asthma Proc (2001) 1.39
Red cell membranes of ankyrin-deficient nb/nb mice lack band 3 tetramers but contain normal membrane skeletons. Biochemistry (1997) 1.37
Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem (1995) 1.36
Lecture on the Action of the Cholera-Poison on the Body; and its Nature and History outside the Body. Br Med J (1870) 1.35
Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol (2001) 1.34
Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors. J Clin Oncol (2000) 1.34
Correlation between radiological and pathological diagnosis of silicosis: an autopsy population based study. Am J Ind Med (1993) 1.34
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res (2001) 1.32
Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.31
Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.30
Approach to the management of complex hepatic injuries. J Trauma (2000) 1.29
Immune evasion genes from filarial nematodes. Int J Parasitol (2001) 1.29
Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia. J Neurol Neurosurg Psychiatry (2006) 1.28
Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res (1994) 1.27
pH regulation of the F-actin binding properties of Dictyostelium elongation factor 1 alpha. J Biol Chem (1995) 1.25
The biological suppression of malaria: an ecological and nutritional interrelationship of a host and two parasites. Am J Clin Nutr (1978) 1.25
Rhabdomyosarcoma of the oral and paraoral region. Cancer (1989) 1.24
Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK. Cell Death Dis (2010) 1.23
Evidence for a microdeletion in 1q32-41 involving the gene responsible for Van der Woude syndrome. Hum Mol Genet (1994) 1.23
Neurologic complications of critical medical illnesses. Crit Care Med (1993) 1.22
Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene (2010) 1.21
Chemical colitis due to endoscope cleaning solutions: a mimic of pseudomembranous colitis. Gastroenterology (1988) 1.20
Penetrating esophageal injuries: time interval of safety for preoperative evaluation--how long is safe? J Trauma (1997) 1.20
Polygons and adhesion plaques and the disassembly and assembly of myofibrils in cardiac myocytes. J Cell Biol (1989) 1.20
Osteosarcoma in preadolescent patients. Clin Orthop Relat Res (2000) 1.20
Prevention of Rh haemolytic disease. Br Med J (1978) 1.19
Effect on outcome of early intensive management of geriatric trauma patients. Br J Surg (2002) 1.18
Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation (1991) 1.17
Epidemiology of major trauma and trauma deaths in Los Angeles County. J Am Coll Surg (1998) 1.17
Privacy in genetics research. Science (1999) 1.17
The topographic organization of repetitive DNA in the human nucleolus. Genomics (1993) 1.17
The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ (2012) 1.16
Acute myeloid leukaemia presenting as cholestatic hepatitis. J Clin Pathol (2004) 1.16
Liberalized screening for blunt carotid and vertebral artery injuries is justified. J Trauma (2001) 1.15
Cross-linking amino acids in collagen and elastin. Am J Clin Nutr (1978) 1.15
ICCE consensus for celiac disease. Endoscopy (2005) 1.15
Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma. J Cancer Res Clin Oncol (1999) 1.14
Power Doppler ultrasound assessment of rheumatoid hand synovitis. J Rheumatol (2001) 1.14